+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

HIV postexposure prophylaxis for children and adolescents



HIV postexposure prophylaxis for children and adolescents



American Journal of Emergency Medicine 18(3): 282-287



HIV postexposure prophylaxis (PEP) is now a well-established part of the management of health care workers after occupational exposures to HIV. Use of PEP for adults exposed to HIV after sexual contact or injection drug use in nonoccupational settings remains controversial with limited data available. There is even less information available concerning HIV PEP for children and adolescents after accidental needlestick injuries or sexual assault. The objective was to describe the current practice of and associated problems with HIV PEP for children and adolescents at an urban academic pediatric emergency department. A retrospective review of all children and adolescents offered HIV PEP between June 1997-June 1998 was conducted. Ten pediatric and adolescent patients were offered HIV PEP, six patients after sexual assault, four patients after needle stick injuries. There were two small children 2 and 3 years of age and eight adolescents. Of these 10 patients, eight were started on HIV PEP. The regimens used for PEP varied; zidovudine, lamivudine, and indinavir were prescribed for in seven patients and zidovudine, lamivudine, and nelfinavir for one other. All 10 patients were HIV negative by serology at baseline testing and all available for follow-up testing (5 of 10) remained HIV negative at 4 to 28 weeks. Only two patients completed the full course of 4 weeks of antiretroviral therapy. Financial concerns, side effects, additional psychiatric and substance abuse issues as well as the degree of parental involvement influenced whether PEP and clinical follow-up was completed. HIV PEP in the nonoccupational setting for children and adolescents presents a medical and management challenge, and requires a coordinated effort at the initial presentation to the health care system and at follow-up. The difficulties encountered in the patients in our series need to be considered before initiating prophylaxis. A provisional management approach to HIV PEP in children and adolescents is proposed.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046203396

Download citation: RISBibTeXText

PMID: 10830685

DOI: 10.1016/s0735-6757(00)90123-2


Related references

Human immunodeficiency virus postexposure prophylaxis for adolescents and children. Pediatrics 108(2): E38, 2001

Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus. Pediatrics 111(6 Pt 1): 1475-1489, 2003

Postexposure prophylaxis for HIV in children and adolescents after sexual assault: a prospective observational study in an urban medical center. Sexually Transmitted Diseases 34(2): 69-70, 2007

Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry. Infection Control and Hospital Epidemiology 21(12): 780-785, 2000

Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review. Clinical Infectious Diseases 60(Suppl. 3): S170-S176, 2015

Postexposure prophylaxis: an intervention to prevent human immunodeficiency virus infection in adolescents. Current Opinion in Pediatrics 15(4): 379-384, 2003

Postexposure management of hepatitis A, B or C: treatment, postexposure prophylaxis and recommendations. Acta Gastro-Enterologica Belgica 66(3): 250-254, 2003

PEPtalk: postexposure prophylaxis against varicella in children with cancer. Archives of Disease in Childhood 96(9): 841-845, 2011

Recommendations for non-occupational postexposure HIV prophylaxis. Spanish Working Group on Non-Occupational Postexposure HIV Prophylaxis of the Catalonian Center for Epidemiological Studies on AIDS and the AIDS Study Group. Enfermedades Infecciosas Y Microbiologia Clinica 20(8): 391-400, 2002

Postexposure prophylaxis of varicella in children with leukemia by oral acyclovir. Pediatrics 97(1): 150-151, 1996

Vaccines for postexposure prophylaxis against varicella (chickenpox) in children and adults. Paediatrics and Child Health 21(2): 91-92, 2016

Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic review. Clinical Infectious Diseases 60(Suppl. 3): S177-S181, 2015

Oseltamivir for influenza postexposure prophylaxis: economic evaluation for children aged 1-12 years in the U.S. American Journal of Preventive Medicine 37(5): 381-388, 2009

Varicella postexposure prophylaxis in children with cancer: urgent need for a randomised controlled trial. Archives of Disease in Childhood 97(9): 853-854, 2012